1995
DOI: 10.1042/cs0880607
|View full text |Cite
|
Sign up to set email alerts
|

Differential Nitric Oxide Synthase Activity in Human Platelets during Normal Pregnancy and Pre-Eclampsia

Abstract: 1. Nitric oxide released from endothelial cells is a potent vasodilator that might play an important role in cardiovascular regulation during pregnancy. Platelets, like endothelial cells, contain a constitutive form of nitric oxide synthase. 2. The present study aimed to measure the activity of this nitric oxide-forming enzyme in normotensive pregnant and non-pregnant women, as well as in women who had developed pre-eclampsia. Nitric oxide synthase activity was measured in the platelets of 21 normotensive preg… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
26
0

Year Published

1996
1996
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 40 publications
(26 citation statements)
references
References 0 publications
0
26
0
Order By: Relevance
“…This is further supported by previous findings of reduced levels of ADMA and enhanced endothelial function, as assessed by flow-mediated dilatation and venous occlusion plethysmography, in normal pregnancy. 26 -28 Such NO-mediated vasodilation, possibly induced by estrogen, 21,22,29 may increase reflection site distance within the vasculature and reduce wave reflection amplitude; thus explaining the reduction in AIx. This contention is supported by the increase in pulse wave transient time observed in our pregnant population.…”
Section: Macedo Et Al Arterial Stiffness In Normal Pregnancymentioning
confidence: 99%
See 1 more Smart Citation
“…This is further supported by previous findings of reduced levels of ADMA and enhanced endothelial function, as assessed by flow-mediated dilatation and venous occlusion plethysmography, in normal pregnancy. 26 -28 Such NO-mediated vasodilation, possibly induced by estrogen, 21,22,29 may increase reflection site distance within the vasculature and reduce wave reflection amplitude; thus explaining the reduction in AIx. This contention is supported by the increase in pulse wave transient time observed in our pregnant population.…”
Section: Macedo Et Al Arterial Stiffness In Normal Pregnancymentioning
confidence: 99%
“…21,22 Indeed, inhibition of NO by intravenous infusion of L-N Gmonomethyl arginine results in increased AIx. 23 Augmentation index has recently been shown to be positively associated with asymmetrical dimethyl-arginine (ADMA), an endogenous inhibitor of NO synthase 24 and inversely correlated with global endothelial function, 25 which is NO dependent.…”
Section: Macedo Et Al Arterial Stiffness In Normal Pregnancymentioning
confidence: 99%
“…There is also evidence that endothelial cell dysfunction is present in women with a pre-eclamptic syndrome and that the resulting decrease in NO but also in prostacyclin synthesis is responsible for the clinical disorders characterizing preeclampsia, i.e., a reduced placental perfusion, an increased sensitivity to vasopressor agents, an activation of the coagulation cascade (Roberts et al, 1991;Rutherford et al, 1995;Baker et al, 1996) and a progressive increase in peripheral resistance and in blood pressure. Thus, a reduced NO synthesis linked to a decreased NO synthase expression or activity has been reported in pre-eclamptic patients (Pinto et al, 1991;Seligman et al, 1994;Delacretaz et al, 1995) although it is disputed by others (Baker et al, 1995). Moreover, the plasma of pre-eclamptic patients has been shown (a) to contain a fraction that inhibits the ability of acetylcholine to relax precontracted rabbit aortic rings (Pinto et al, 1992), but also (b) to reduce endothelial prostacyclin production (Ramsay et al, 1994).…”
Section: Introductionmentioning
confidence: 99%
“…Several investigators have reported various risk factors to the causes of this prenatal group of conditions including preeclampsia, PIH, ecclampsia, abruption placentae, and HELLP syndrome, [3][4][5][6][7][8][9][10][11][12]. Coagulopathy is one of the major risk factors, and several authors have reported genetic polymorphisms including vascular endothelial growth factor, prothrombin gene polymorphisms, methylenetetrahydrofolate reductase, factor V Leiden, several interleukins, and polymorphisms in the genes involved in nitric oxide synthesis, [3][4][5][6][7][8][9][10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…Coagulopathy is one of the major risk factors, and several authors have reported genetic polymorphisms including vascular endothelial growth factor, prothrombin gene polymorphisms, methylenetetrahydrofolate reductase, factor V Leiden, several interleukins, and polymorphisms in the genes involved in nitric oxide synthesis, [3][4][5][6][7][8][9][10][11][12].…”
Section: Introductionmentioning
confidence: 99%